rethinkTHC Search
Menu
Study breakdown

Cannabis in cancer: helpful for symptoms, but could it interfere with immunotherapy?

ReviewModerate evidence
The takeaway

Cannabis is useful for cancer-related pain and nausea, and preclinical data suggest anti-tumor properties, but its immunomodulatory effects could potentially interfere with cancer immunotherapy and bone marrow transplants.

Oncologists, cancer patients using cannabis, and immunotherapy researchers.

Potential conflict between cannabis and cancer immunotherapy

What the researchers found

Current cancer applications of cannabinoids are mainly palliative (pain and anti-emetic effects). Preclinical data on anti-proliferative properties remain inconsistent, with no conclusive animal model or clinical trial data. Critically, the immunomodulatory effects of cannabinoids may conflict with cancer immunotherapy and bone marrow transplant approaches, where robust immune function is essential.

Why it matters

As immunotherapy becomes a standard cancer treatment, the potential for cannabis to dampen the immune response it relies on is a clinically important but understudied concern.

The numbers in context

No specific clinical outcome data. Review synthesized preclinical and clinical knowledge about cannabinoid immunomodulation in oncology.

How the study worked

Review covering preclinical models, limited clinical data, and the specific concern about interactions between cannabinoid immunomodulation and cancer immunotherapy.

What this study cannot tell us

Narrative review. Anti-tumor data are preclinical and inconsistent. Immunomodulatory interactions with immunotherapy are theoretical. No clinical trials address this interaction.

How to read the evidence

Thoughtful review raising an important clinical question, but based on indirect evidence and theoretical concerns.

When this study was published

2020 review.

The bigger picture

The potential contradiction between cannabis's anti-tumor properties and its immune-dampening effects highlights the complexity of using cannabinoids alongside modern cancer treatments.

Questions still open

  • Should cancer patients on immunotherapy avoid cannabis? Could timed or targeted cannabinoid dosing avoid immune interference?

Common questions

Should cancer patients use cannabis during immunotherapy?
This review raises concern that cannabis's immunomodulatory effects could potentially interfere with cancer immunotherapy, which relies on a strong immune response. The interaction has not been studied in clinical trials.
Can cannabis fight cancer directly?
Preclinical data show some anti-proliferative effects, but results are inconsistent and no clinical trials have confirmed direct anti-tumor benefits in patients.

Read the original research

The Highs and Lows of Cannabis in Cancer Treatment and Bone Marrow Transplantation.

Rambam Maimonides medical journal, 11(1)

Citation

Almogi-Hazan, Osnat; Khuja, Iman; Ritter, Sivan; Or, Reuven. (2020). The Highs and Lows of Cannabis in Cancer Treatment and Bone Marrow Transplantation.. Rambam Maimonides medical journal, 11(1). https://doi.org/10.5041/RMMJ.10391

Explore the wider topic